The compounds classified as Vmn2r16 Inhibitors represent a selection of chemical agents that, through their action on various signaling molecules and pathways, have the potential to indirectly modulate the activity of Vmn2r16. These compounds act on a range of targets, from kinases and phosphatases to ion channels and regulatory proteins, affecting the cellular processes and signaling cascades that are crucial for the function of proteins like Vmn2r16. The indirect modulation of Vmn2r16 through these compounds highlights the interconnected nature of cellular signaling networks, where changes in one part of the system can influence the activity of seemingly distant proteins.
This approach to the modulation of Vmn2r16 underscores the complexity of signaling mechanisms within the cell, demonstrating how strategic intervention at various points in the signaling network can offer insights into the functional roles of specific receptors like Vmn2r16. By targeting key nodes within these networks-such as kinase activity, calcium dynamics, and phosphatase function-the listed chemicals provide a means to explore the regulatory mechanisms that govern the activity of Vmn2r16 and its role in cellular signaling. Through such exploration, these inhibitors not only facilitate a deeper understanding of Vmn2r16's biological functions but also exemplify the broader principles of signal transduction, highlighting the potential of indirect modulation as a strategy for investigating the complex interplay of signaling pathways within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, potentially altering phosphorylation states of proteins in pathways associated with Vmn2r16. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
Blocks Ca2+/calmodulin-dependent protein kinase II, which could affect calcium signaling pathways linked to Vmn2r16's function. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $176.00 $624.00 | 3 | |
SERCA inhibitor, increases intracellular Ca2+ levels, potentially influencing calcium-dependent pathways associated with Vmn2r16. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, could alter kinase-mediated signaling pathways that intersect with Vmn2r16's signaling mechanisms. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits protein kinase C, potentially impacting PKC-mediated signaling pathways relevant to Vmn2r16's activity. | ||||||
Cdc2-Like Kinase Inhibitor, TG003 | 300801-52-9 | sc-202528 sc-202528A | 5 mg 25 mg | $139.00 $548.00 | 6 | |
Irreversible inhibitor of EGFR kinase, could affect signaling pathways that indirectly modulate Vmn2r16 activity. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits Rac1, potentially affecting actin cytoskeleton dynamics and signaling pathways relevant to Vmn2r16. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, affecting AKT signaling pathways that could be relevant to Vmn2r16's signaling context. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor, potentially impacts the MAPK/ERK signaling pathways that Vmn2r16 might be involved in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, potentially modulating stress response signaling pathways associated with Vmn2r16. | ||||||